Drug application
PRISMASOL BK 0/3.5 IN PLASTIC CONTAINER (CALCIUM CHLORIDE, DEXTROSE, LACTIC ACID and 4 more)
Drugs@FDA NDA 021703 · VANTIVE US HLTHCARE
Key facts
| Drug name | PRISMASOL BK 0/3.5 IN PLASTIC CONTAINER |
|---|---|
| Active ingredients | CALCIUM CHLORIDE, DEXTROSE, LACTIC ACID, MAGNESIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM CHLORIDE |
| Application type | NDA |
| Application number | 021703 |
| Company | VANTIVE US HLTHCARE |
| Dosage forms | INJECTABLE, INJECTION |
| Strength | 5.15GM/1000ML;N/A/1000ML;5.4GM/1000ML;2.03GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML) |
| Marketing status | Discontinued |
| Reference listed drug | Yes |
| Latest submission class | Type 3 - New Dosage Form |
| Latest submission status date | Oct 25, 2006 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- 1–9 Label versions
- 10–99 Products
- None Therapeutic equivalents
- Yes FDA letters on file
- Yes FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: